ReviewNeuroscience insights2025
The Flipons, Infections, and Amyloids that Foreshadow the Fading Memories of Alzheimer's Disease.
Review in Neuroscience insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our memories are almost magical. We can experience an event for a short moment in time and quickly recall it decades later. This review explores the impact of some relatively new discoveries in the field of flipon biology that provide insight into diseases associated with impaired memory function. I examine how an ancient immune system based on Z-DNA and Z-RNA (collectively called ZNAs) regulates pathways that impact the memories modeled by synapses. The outcomes depend on intracellular defenses activated by endogenous retroelements (ERE) and virus, and on extracellular responses to ZNAs in bacterial biofilms. The bacterial amyloids and complement activation pathways further exacerbate the decline of cognitive and affective functions by inducing remodeling of synapses. In addition to immune EREs, a class of memory EREs potentially acts as ribotransmitters. These RNAs are transported across the synapse to program the connections between neurons that underlie the formation and remodeling of memories. Examples exist of ribotransmitters derived from ERE transcripts and assembled into capsids capable of transsynaptic transmission. In contrast, the immune EREs protect the nervous system by dismantling synapses to prevent viruses and retrotransposons from crossing them. The complexity of the interactions between memory and immune EREs likely give rise to the inverted U-shaped dose-response curves for the therapeutics currently available to treat cognitive decline. Other approaches for disease prevention are suggested, along with those that promote the regeneration and reprogramming of neuronal circuits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.